Business Description
Alk-Abello AS
ISIN : DK0061802139
Share Class Description:
WBO:ALKB: Class BTotal Employee Number:
2,759Compare
Compare
Traded in other countries / regions
ALK B.Denmark0OIR.UKALKB.AustriaAKBLF.USA4AJ0.Germany IPO Date
2026-03-10Description
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.77 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.19 | |||||
Interest Coverage | 60.52 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 14.95 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | 41.1 | |||||
3-Year EPS without NRI Growth Rate | 52.9 | |||||
3-Year FCF Growth Rate | 184.6 | |||||
3-Year Book Growth Rate | 17.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 15.58 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 13.52 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.7 | |||||
9-Day RSI | 43.78 | |||||
14-Day RSI | 47.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.25 | |||||
Quick Ratio | 2.01 | |||||
Cash Ratio | 1.08 | |||||
Days Inventory | 301.8 | |||||
Days Sales Outstanding | 56.6 | |||||
Days Payable | 24.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.62 | |||||
Dividend Payout Ratio | 0.28 | |||||
Forward Dividend Yield % | 0.62 | |||||
5-Year Yield-on-Cost % | 0.62 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 1.15 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.76 | |||||
Operating Margin % | 26.75 | |||||
Net Margin % | 19.51 | |||||
EBITDA Margin % | 32.13 | |||||
FCF Margin % | 27.37 | |||||
OCF Margin % | 33.36 | |||||
ROE % | 20.84 | |||||
ROA % | 14.79 | |||||
ROIC % | 19.68 | |||||
3-Year ROIIC % | 50.3 | |||||
ROC (Joel Greenblatt) % | 45.82 | |||||
ROCE % | 24.57 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 44.19 | |||||
Forward PE Ratio | 35.87 | |||||
PE Ratio without NRI | 44.19 | |||||
Shiller PE Ratio | 168.61 | |||||
Price-to-Owner-Earnings | 30.92 | |||||
PEG Ratio | 1.16 | |||||
PS Ratio | 8.63 | |||||
PB Ratio | 8.64 | |||||
Price-to-Tangible-Book | 11.88 | |||||
Price-to-Free-Cash-Flow | 31.5 | |||||
Price-to-Operating-Cash-Flow | 25.85 | |||||
EV-to-EBIT | 31.46 | |||||
EV-to-EBITDA | 26.37 | |||||
EV-to-Revenue | 8.47 | |||||
EV-to-FCF | 30.21 | |||||
Price-to-GF-Value | 1.26 | |||||
Price-to-Projected-FCF | 4.82 | |||||
Price-to-Median-PS-Value | 1.5 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.77 | |||||
Price-to-Graham-Number | 4.83 | |||||
| Price-to-Net-Current-Asset-Value | 29.25 | |||||
Earnings Yield (Greenblatt) % | 3.18 | |||||
FCF Yield % | 3.17 | |||||
Forward Rate of Return (Yacktman) % | 20.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Alk-Abello AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 878.654 | ||
| EPS (TTM) (€) | 0.778 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 47.93 | ||
| 14-Day ATR (€) | 0.621848 | ||
| 20-Day SMA (€) | 35.034 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 27.1 - 36.16 | ||
| Shares Outstanding (Mil) | 221.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alk-Abello AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alk-Abello AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-18 | In 145 days | ||
| Third quarter earnings results for 2026 | 2026-11-18 | In 145 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-20 | In 55 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 55 days | ||
| First quarter earnings conference call for 2026 | 2026-05-05 13:30 | 34.52 (+5.82%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 34.52 (+5.82%) | ||
| DKK 1.600000 Cash Dividend | 2026-03-17 | -- | ||
| General meeting for 2026 | 2026-03-16 16:00 | -- | ||
| Annual report for 2025 | 2026-02-20 13:30 | -- | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-20 13:30 | -- |
Show
Entries
Alk-Abello AS Frequently Asked Questions
What is Alk-Abello AS(WBO:ALKB)'s stock price today?
The current price of WBO:ALKB is €34.22. The 52 week high of WBO:ALKB is €36.16 and 52 week low is €27.10.
When is next earnings date of Alk-Abello AS(WBO:ALKB)?
The next earnings date of Alk-Abello AS(WBO:ALKB) is 2026-08-20.
Does Alk-Abello AS(WBO:ALKB) pay dividends? If so, how much?
The Dividend Yield % of Alk-Abello AS(WBO:ALKB) is 0.62% (As of Today), Highest Dividend Payout Ratio of Alk-Abello AS(WBO:ALKB) was 0.28. The lowest was 0.18. And the median was 0.18. The Forward Dividend Yield % of Alk-Abello AS(WBO:ALKB) is 0.62%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Alk-Abello AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers